July 6, 2021 -- Eurekare has entered an agreement with DNAlytics to develop Eurekare's proprietary artificial intelligence (AI) platform to support its biotech startup studios.
Eurekare is focused on financing and building biotechnology companies in the microbiome and synthetic biology fields. It supports biotech startups via its studios: Eurekabiome based in France for the microbiome field and Eurekasynbio based in Belgium for synthetic biology.
The company also invests in more mature biotech companies in Europe.
As part of the new collaboration, the new AI platform will help the company identify leading academic researchers, locate new ideas and approaches in development, and help scale existing portfolio companies, according to Eurekare.
Financial details of the agreement were not disclosed.
Copyright © 2021 scienceboard.net